21
Thu, Nov
45 New Articles

NKO Partners and BD2P Advise on Dr. Max Group’s Acquisition of Zlatni Lav Pharmacies

NKO Partners and BD2P Advise on Dr. Max Group’s Acquisition of Zlatni Lav Pharmacies

Serbia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

NKO Partners has advised the Dr. Max Group on its acquisition of Serbian pharmacy chain Zlatni Lav. Bojovic Draskovic Popovic & Partners advised the seller.

According to NKO, following the acquisition, Dr. Max operates more than 180 pharmacies in Serbia. Dr. Max is a pharmacy chain operating in Central and Eastern Europe. The company has over 2,200 pharmacies in six countries, including the Czech Republic, Slovakia, Poland, Romania, Serbia, and Italy.

The NKO team was led by Partner Djordje Nikolic and Senior Associate Branko Jankovic.

The BD2P team was led by Partner Uros Popovic and Senior Associate Stefan Golubovic.

Serbia Knowledge Partner

SOG in cooperation with Kinstellar is a full-service business law firm in Serbia that provides foreign and domestic clients with premium-quality legal advice and assistance across a wide range of key areas of corporate law. The firm was founded in 2015 by a group of seasoned, internationally-trained lawyers. SOG has developed a distinctively dynamic culture, bringing together top talent, fostering entrepreneurship, and maintaining exceptional relationships with its clients.

SOG has achieved consistent growth in the volume of its business, accompanied by an exponential increase in the number of hired associate lawyers and the firm’s network of business contacts. SOG has a robust client base of multinationals, investment and private equity firms, and financial institutions. Clients praise SOG for being commercially minded, very responsive and knowledgeable.

Establishing permanent cooperation with Kinstellar is part of realising SOG's long-term development strategy to be the leading provider of legal services in the Western Balkans market.

Firm's website: https://www.kinstellar.com/

 

Our Latest Issue